Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mehul Patel

Showing results (171-180 of 202) with videos related to

Pageof 21
Sort By:
American Journal of Translational Research|May 19, 2025
Adenosine receptor subtype modulators: Insight into molecular mechanisms and their therapeutic applicationNilay Solanki, Rohinee Dodiya, Dhruvi Vejpara, et al.
Respiratory Medicine|April 22, 2017
The role of serum amyloid A staining of granulomatous tissues for the diagnosis of sarcoidosisAlbert Huho, Llewellyn Foulke, Timothy Jennings, et al.
ALTEX|May 3, 2022
Validation of the monocyte activation test with three therapeutic monoclonal antibodiesRuth Daniels, Wim Van der Elst, Nele Dieltjens, et al.
BMJ Open Gastroenterology|September 7, 2021
Diarrhoea and preadmission antibiotic exposure in COVID-19: a retrospective cohort study of 1153 hospitalised patientsBilal Akhter Mateen, Sandip Samanta, Sebastian Tullie, et al.
Therapeutic Advances in Respiratory Disease|February 12, 2026
Bioequivalence of budesonide/glycopyrrolate/formoterol fumarate with a next-generation propellant versus hydrofluoroalkane-134a in healthy adults: phase I, randomized, double-blind, single-dose, partial-replicate, three-way cross-over lung exposure and total systemic exposure studiesArtur Bednarczyk, Magnus Aurivillius, Mandeep Jassal, et al.
Leukemia & Lymphoma|May 30, 2009
Bortezomib in combination with pegylated liposomal doxorubicin and thalidomide is an effective steroid independent salvage regimen for patients with relapsed or refractory multiple myeloma: results of a phase II clinical trialAsher Chanan-Khan, Kena C Miller, Laurie Musial, et al.
American Journal of Respiratory and Critical Care Medicine|August 30, 2024
Effect of Triple Therapy on Cardiovascular and Severe Cardiopulmonary Events in Chronic Obstructive Pulmonary Disease: A <i>Post Hoc</i> Analysis of a Randomized, Double-Blind, Phase 3 Clinical Trial (ETHOS)Dave Singh, Fernando J Martinez, John R Hurst, et al.
Journal of Crohn'S & Colitis|April 14, 2020
Real-world Effectiveness of Tofacitinib for Moderate to Severe Ulcerative Colitis: A Multicentre UK ExperienceSailish Honap, Desmond Chee, Thomas P Chapman, et al.
Heart Rhythm|March 10, 2015
Neuronally released vasoactive intestinal polypeptide alters atrial electrophysiological properties and may promote atrial fibrillationYutao Xi, Zhi-Yang James Chao, Wen Yan, et al.
ERJ Open Research|December 24, 2025
Effect of budesonide/glycopyrronium/formoterol fumarate dihydrate on cardiopulmonary outcomes in COPD: rationale and design of the THARROS trialFernando J Martinez, John R Hurst, MeiLan K Han, et al.
Pageof 21

Showing results (171-180 of 202) with videos related to

Sort By:
Pageof 21
American Journal of Translational Research|May 19, 2025
Adenosine receptor subtype modulators: Insight into molecular mechanisms and their therapeutic applicationNilay Solanki, Rohinee Dodiya, Dhruvi Vejpara, et al.
Respiratory Medicine|April 22, 2017
The role of serum amyloid A staining of granulomatous tissues for the diagnosis of sarcoidosisAlbert Huho, Llewellyn Foulke, Timothy Jennings, et al.
ALTEX|May 3, 2022
Validation of the monocyte activation test with three therapeutic monoclonal antibodiesRuth Daniels, Wim Van der Elst, Nele Dieltjens, et al.
BMJ Open Gastroenterology|September 7, 2021
Diarrhoea and preadmission antibiotic exposure in COVID-19: a retrospective cohort study of 1153 hospitalised patientsBilal Akhter Mateen, Sandip Samanta, Sebastian Tullie, et al.
Therapeutic Advances in Respiratory Disease|February 12, 2026
Bioequivalence of budesonide/glycopyrrolate/formoterol fumarate with a next-generation propellant versus hydrofluoroalkane-134a in healthy adults: phase I, randomized, double-blind, single-dose, partial-replicate, three-way cross-over lung exposure and total systemic exposure studiesArtur Bednarczyk, Magnus Aurivillius, Mandeep Jassal, et al.
Leukemia & Lymphoma|May 30, 2009
Bortezomib in combination with pegylated liposomal doxorubicin and thalidomide is an effective steroid independent salvage regimen for patients with relapsed or refractory multiple myeloma: results of a phase II clinical trialAsher Chanan-Khan, Kena C Miller, Laurie Musial, et al.
American Journal of Respiratory and Critical Care Medicine|August 30, 2024
Effect of Triple Therapy on Cardiovascular and Severe Cardiopulmonary Events in Chronic Obstructive Pulmonary Disease: A <i>Post Hoc</i> Analysis of a Randomized, Double-Blind, Phase 3 Clinical Trial (ETHOS)Dave Singh, Fernando J Martinez, John R Hurst, et al.
Journal of Crohn'S & Colitis|April 14, 2020
Real-world Effectiveness of Tofacitinib for Moderate to Severe Ulcerative Colitis: A Multicentre UK ExperienceSailish Honap, Desmond Chee, Thomas P Chapman, et al.
Heart Rhythm|March 10, 2015
Neuronally released vasoactive intestinal polypeptide alters atrial electrophysiological properties and may promote atrial fibrillationYutao Xi, Zhi-Yang James Chao, Wen Yan, et al.
ERJ Open Research|December 24, 2025
Effect of budesonide/glycopyrronium/formoterol fumarate dihydrate on cardiopulmonary outcomes in COPD: rationale and design of the THARROS trialFernando J Martinez, John R Hurst, MeiLan K Han, et al.
Pageof 21